HPGDS and lung disorder: Alteration of the production profiles of PGs in vivo (e.g., PGE2 vs. PGD2 ratio) is a critical determinant in the development of many diseases including cancer [8], atherosclerosis [9], arthritis [10], and pulmonary diseases [11], [12].